Be recognised for the part you play in targets being met
Ongoing training and development is key to a happy, motivated sales force and now, the PharmaTimes Sales Awards has a category dedicated to the people who make it happen.
19th July 2018
Latest news
Industry shows support for new Medical & Scientific Excellence Awards
News of the inaugural Medical & Scientific Excellence Awards has got the industry talking, with a number of entries already received.
19th July 2018
Want to make a difference? Enter the new Charity Challenge
PharmaTimes media is partnering with Bowel Cancer UK and Beating Bowel Cancer to launch a Charity Challenge Award as part of the Communications Team of the Year competition.
19th July 2018
Fly your company's flag - ENTER NOW
With just six weeks to go until the prestigious PharmaTimes Marketer of the Year closes for entry, marketers at all levels of their career are looking forward to taking part in the 25th anniversary celebrations.
19th July 2018
Sub-cutaneous form of Entyvio hits PhIII safety, efficacy goals
Takeda says it has late-stage trial results showing the benefit of an investigational subcutaneous formulation of Entyvio to patients with ulcerative colitis.
19th July 2018
Kisqali wins speedy US breast cancer nod
Novartis’ Kisqali has been approved for breast cancer in the US less than one month after being filed with the US Food and Drug Administration.
19th July 2018
Four pharmas named for breaching ABPI Code of Practice
Martindale Pharma, Pierre Fabre, Janssen and Pharmasure have all been named in advertisements for breaching the Association of the British Pharmaceutical Industry’s Code of Practice.
19th July 2018
Dementia accounts for 12.7 percent of deaths
New data has revealed that Alzheimer’s disease and other forms of dementia accounted for 12.7 percent of all deaths in England and Wales last year.
19th July 2018
Novartis bags rights to Galapagos/MorphoSys atopic dermatitis drug
Novartis has signed an exclusive global license agreement with Galapagos and MorphoSys for MOR106, a novel antibody directed against IL-17C.
19th July 2018
NICE calls for quicker treatment of kidney stone patients in pain
The National Institute for Health and Care Excellence has released new draft guidelines calling for faster treatment of patients with kidney stones experiencing severe pain.
18th July 2018
Record numbers taking part in life sciences industry research
The number of people taking part in NHS clinical research studies sponsored by the life sciences industry has risen dramatically over the last year, show new figures by the National Institute for Health Research (NIHR).
18th July 2018
US approves Janssen’s HIV pill Symtuza
Janssen’s Symtuza has been approved US regulators as the first and only complete, darunavir-based single-tablet regimen for the treatment of HIV in adults.
18th July 2018
MPs vote for UK to remain part of EMA
MPs have voted 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit.
18th July 2018
Vertex mulls over NHS England’s offer for CF drugs
Vertex Pharmaceuticals is considering a final offer from NHS England on funding for its cystic fibrosis therapies, but said it remains concerned that the deal on the table does not fully reflect the value of its existing and future medicines for the condition.
18th July 2018
Roche’s antiviral hits flu targets in PhIII trial
Roche says its investigational flu drug baloxavir marboxil, in-licensed from Japan’s Shionogi, has met key goals in a late-stage trial.
17th July 2018
